Market Place
Sourcing Support
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
Top Pharma & Biotech Deals, Investments, M&As in September 2018
As
compared to the previous months, September was a slower month for dealmaking.
The Wall Street J
GSK, Google form first bioelectronics firm; 11 generic companies benefit from the Teva Allergan deal
This week,
Phispers brings to you the details of the bioelectronics firm formed by GSK and
Google. T
Data integrity has no relationship with product quality
Peter J. Werth, President and Chief Executive Officer, ChemWerth, a US-headquartered full-service ge
